课题基金 / 基金详情

Functional analysis of LATS2 for a conquest of tumorigenic activity of ES and iPS cells

Functional analysis of LATS2 for a conquest of tumorigenic activity of ES and iPS cells
LATS2 征服 ES 和 iPS 细胞致瘤活性的功能分析
批准号:
21790290
负责人:
HISHIDA Tomoaki
金额:
$2.75万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Young Scientists (B)
财政年份:
2009
资助国家:
日本
项目状态:
已结题
起止时间:
2009 至 2010

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
ES and iPS cells have not only pluripotency but also tumorigenic activity, and we therefore must overcome their oncogenic property. We focused on LATS2, a tumor suppressor gene and examined the role and involvement of LATS2 in tumorigenic activity of ES cells. We found that forced LATS2 expression reduced the cell growth and oncogenic property of ES cells. However, several studies indicated that LATS2 protein expression gradually declined as ES cells grew, suggesting that there might exist the protein degradation system for the factors having anti-oncogenic activity in ES cells.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
瘤内链球菌促进STAT3的O-GlcNAc修饰驱动鼻咽癌免疫抑制微环境的机制研究
  • 批准号:
    JCZRLH202600778
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
  • 依托单位:
SDC1通过MMP11+CAF的细胞外基质重塑促进子宫颈癌化学免疫联合治疗耐药的机制研究
  • 批准号:
    JCZRQNB202600504
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
  • 依托单位:
多模态精准导航引导肝内胆管癌淋巴结清扫的动态示踪与机制探索
抗BNLF2b抗体联合circRNA构建鼻咽癌早期诊断模型及机制研究